{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:09:16Z","timestamp":1788858556381,"version":"build-2803163510"},"reference-count":32,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Fengtai District Key Clinical Specialty Development Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Pineal region tumors (PRTs) are rare and biologically heterogeneous neoplasms with overlapping clinical and radiological features. Low-level cerebrospinal fluid (CSF) beta-human chorionic gonadotropin (\u03b2-hCG) may support a clinical diagnosis of germinoma (GE); however, its pathological specificity remains uncertain. Methods: We retrospectively reviewed four patients with low-level CSF \u03b2-hCG elevation whose available tissue specimens demonstrated pineal parenchymal tumors (PPTs). Tissue was obtained before systemic treatment in two patients and after platinum-based chemotherapy in two. Results: All four patients were male and aged 8 to 19 years. Pretreatment specimens from two patients demonstrated pineal parenchymal tumors of intermediate differentiation (PPTID), whereas postchemotherapy specimens from the other two demonstrated pineoblastoma (PB). Serum \u03b2-hCG was &lt;0.1 IU\/L in all patients, while CSF \u03b2-hCG ranged from 2.86 to 18.29 IU\/L; serum and CSF alpha-fetoprotein (AFP) levels were normal. Two patients received platinum-based chemotherapy for presumptive intracranial germ cell tumors before tissue diagnosis, achieving stable disease or partial response. Because their specimens were obtained after chemotherapy, an occult pretreatment germ cell component could not be excluded. Conclusions: Although contemporary diagnostic protocols allow a clinical diagnosis of GE with characteristic imaging findings and low-level \u03b2-hCG elevation, isolated low-level CSF \u03b2-hCG immunoreactivity may also coexist with tissue specimens demonstrating PPT and should therefore not be considered pathognomonic for GE or interpreted in isolation. Early tissue acquisition with integrated histopathological and molecular evaluation is essential to avoid diagnostic misclassification and ensure appropriate treatment.<\/jats:p>","DOI":"10.3390\/jcm15186934","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:10:22Z","timestamp":1788855022000},"page":"6934","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-Level Cerebrospinal Fluid \u03b2-hCG Elevation in Patients with Pineal Parenchymal Tumors: A Four-Case Series and Diagnostic Caution"],"prefix":"10.3390","volume":"15","author":[{"given":"Yixuan","family":"He","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhong","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-4487","authenticated-orcid":false,"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing 100045, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00381-023-06081-1","article-title":"Pineal\/germ cell tumors and pineal parenchymal tumors","volume":"39","author":"Ogiwara","year":"2023","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lombardi, G., Poliani, P.L., Manara, R., Berhouma, M., Minniti, G., Tabouret, E., Razis, E., Cerretti, G., Zagonel, V., and Weller, M. (2022). Diagnosis and treatment of pineal region tumors in adults: A EURACAN overview. Cancers, 14.","DOI":"10.3390\/cancers14153646"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1200\/JCO.23.01747","article-title":"Adolescents and Young Adults with Cancer: CNS Tumors","volume":"42","author":"Wu","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yeo, K.K., Gell, J., Dhall, G., and Lau, C. (2025). Intracranial germ cell tumors: Advancement in genomic diagnostics and the need for novel therapeutics. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1513258"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/neuonc\/noab252","article-title":"EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","volume":"24","author":"Frappaz","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/neuonc\/noac057","article-title":"Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials","volume":"24","author":"Fonseca","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/pbc.21741","article-title":"The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors","volume":"51","author":"Kim","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/head.12246","article-title":"The CARE guidelines: Consensus-based clinical case reporting guideline development","volume":"53","author":"Gagnier","year":"2013","journal-title":"Headache J. Head Face Pain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"vdag086","DOI":"10.1093\/noajnl\/vdag086","article-title":"Genetic landscape and molecular targets in pediatric pineal tumors","volume":"8","author":"Pasquinelli","year":"2026","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-024-04565-x","article-title":"Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or \u03b2-HCG level higher than 500 IU\/L","volume":"166","author":"Feng","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Takami, H., and Ichimura, K. (2022). Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.982608"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"wuaf007","DOI":"10.1093\/neuped\/wuaf007","article-title":"Central nervous system germ cell tumors: Discrepancies in diagnosis and management across the world","volume":"1","author":"Baroni","year":"2025","journal-title":"Neuro-Oncol. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40001-016-0204-2","article-title":"An update on the clinical diagnostic value of \u03b2-hCG and \u03b1FP for intracranial germ cell tumors","volume":"21","author":"Hu","year":"2016","journal-title":"Eur. J. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2019.11.JNS191576","article-title":"Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts","volume":"134","author":"Takami","year":"2020","journal-title":"J. Neurosurg."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"De Felici, M., Klinger, F.G., Campolo, F., Balistreri, C.R., Barchi, M., and Dolci, S. (2021). To be or not to be a germ cell: The extragonadal germ cell tumor paradigm. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115982"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"vdac062","DOI":"10.1093\/noajnl\/vdac062","article-title":"Rare central nervous system tumors in adults: A population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors","volume":"4","author":"Ho","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/neuonc\/not050","article-title":"Bifocal intracranial tumors of nongerminomatous germ cell etiology: Diagnostic and therapeutic implications","volume":"15","author":"Aizer","year":"2013","journal-title":"Neuro-Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-019-03088-7","article-title":"Treatment and survival of primary intracranial germ cell tumors: A population-based study using SEER database","volume":"146","author":"Denyer","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"03000605251390080","DOI":"10.1177\/03000605251390080","article-title":"An integrated cerebrospinal fluid beta-human chorionic gonadotropin and atrophy-targeted magnetic resonance imaging strategy to reduce diagnostic delays in bilateral basal ganglia germinomas: A case series","volume":"53","author":"Dong","year":"2025","journal-title":"J. Int. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2350\/14-02-1436-OA.1","article-title":"Significant immunohistochemical expression of human chorionic gonadotropin in high-grade osteosarcoma is rare, but may be associated with clinically elevated serum levels","volume":"17","author":"Lee","year":"2014","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/pbc.24097","article-title":"Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma","volume":"59","author":"Allen","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40478-023-01682-y","article-title":"Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors","volume":"11","author":"Zhang","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40478-025-02148-z","article-title":"Elevation of hCG in CSF in pinealoblastoma: A pitfall rescued by pathological examination","volume":"13","author":"Bouille","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nwabuobi, C., Arlier, S., Schatz, F., Guzeloglu-Kayisli, O., Lockwood, C.J., and Kayisli, U.A. (2017). hCG: Biological functions and clinical applications. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102037"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00401-021-02284-5","article-title":"Clinical and molecular heterogeneity of pineal parenchymal tumors: A consensus study","volume":"141","author":"Liu","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s42003-020-01267-8","article-title":"Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets","volume":"3","author":"Kubota","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noab246","article-title":"12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors","volume":"24","author":"Satomi","year":"2022","journal-title":"Neuro-Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/nop\/npad067","article-title":"Final report of the phase II NEXT\/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors","volume":"11","author":"Shatara","year":"2024","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14326","DOI":"10.1038\/s41598-020-71161-0","article-title":"Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors","volume":"10","author":"Takayasu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-022-03440-2","article-title":"All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: Histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant","volume":"482","author":"Wolf","year":"2023","journal-title":"Virchows Arch."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Li, M., Liu, J., Deng, K., Zhu, H., Lu, L., Pan, H., Wang, R., and Yao, Y. (2023). OCT3\/4 is a potential immunohistochemical biomarker for diagnosis and prognosis of primary intracranial germ cell tumors: A systematic review and meta-analysis. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1169179"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/6934\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:29:58Z","timestamp":1788856198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/6934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15186934"],"URL":"https:\/\/doi.org\/10.3390\/jcm15186934","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}